Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG.

Nat Med. 2011 Feb;17(2):211-5. doi: 10.1038/nm.2284. Epub 2011 Jan 16.

2.

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, Bader AG.

Cancer Res. 2010 Jul 15;70(14):5923-30. doi: 10.1158/0008-5472.CAN-10-0655. Epub 2010 Jun 22.

3.

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes.

Takeshita F, Patrawala L, Osaki M, Takahashi RU, Yamamoto Y, Kosaka N, Kawamata M, Kelnar K, Bader AG, Brown D, Ochiya T.

Mol Ther. 2010 Jan;18(1):181-7. doi: 10.1038/mt.2009.207. Epub 2009 Sep 8.

4.

Methodologies in assaying prostate cancer stem cells.

Li H, Jiang M, Honorio S, Patrawala L, Jeter CR, Calhoun-Davis T, Hayward SW, Tang DG.

Methods Mol Biol. 2009;568:85-138. doi: 10.1007/978-1-59745-280-9_7.

PMID:
19582423
5.

Functional evidence that the self-renewal gene NANOG regulates human tumor development.

Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG.

Stem Cells. 2009 May;27(5):993-1005. doi: 10.1002/stem.29.

6.

Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.

Bhatia B, Jiang M, Suraneni M, Patrawala L, Badeaux M, Schneider-Broussard R, Multani AS, Jeter CR, Calhoun-Davis T, Hu L, Hu J, Tsavachidis S, Zhang W, Chang S, Hayward SW, Tang DG.

J Biol Chem. 2008 Oct 10;283(41):27957-72. doi: 10.1074/jbc.M803467200. Epub 2008 Jul 28.

7.

The let-7 microRNA reduces tumor growth in mouse models of lung cancer.

Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG, Slack FJ.

Cell Cycle. 2008 Mar 15;7(6):759-64. Epub 2008 Mar 3.

PMID:
18344688
8.

Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT.

Bhatia B, Multani AS, Patrawala L, Chen X, Calhoun-Davis T, Zhou J, Schroeder L, Schneider-Broussard R, Shen J, Pathak S, Chang S, Tang DG.

Int J Cancer. 2008 Apr 1;122(7):1483-95.

9.

Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.

Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG.

Cancer Res. 2007 Jul 15;67(14):6796-805. Erratum in: Cancer Res. 2007 Sep 15;67(18):8973.

10.

Prostate cancer stem/progenitor cells: identification, characterization, and implications.

Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R, Jeter C.

Mol Carcinog. 2007 Jan;46(1):1-14. Review.

PMID:
16921491
11.

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.

Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG.

Oncogene. 2006 Mar 16;25(12):1696-708.

PMID:
16449977
12.

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG.

Cancer Res. 2005 Jul 15;65(14):6207-19.

Supplemental Content

Loading ...
Support Center